Sort
21,281 grants matching “influenza”
Task B10: In Vitro Assessment for Antimicrobial Activity for Respiratory Viruses
$64,000Southern Research Institute · N01 · FY2012 · AI
Sub-phenotyping pneumonia by lung pathobiology
$63,970Bradley Hiller · Boston University Medical Campus · F32 · FY2024 · HL
Public Health Strategies for the Next Influenza Pandemic
$63,902Nayer Khazeni · Stanford University · F32 · FY2009 · HS
Regulation of IL10 production in CD8+ T cells during Flu infection by tyrosine kinase Itk
$63,708Avery August · Cornell University · R01 · FY2021 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$63,562Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2018 · AI
VTEU: Phase II Influenza Vaccine Trial
$63,449Wendy Keitel · Baylor College Of Medicine · N01 · FY2016 · AI
Key determinants of dengue virus neutralization by naturally occurring human mAbs
$63,400Scott Alan Smith · Vanderbilt University · K08 · FY2015 · AI
Public Health Strategies for the Next Influenza Pandemic
$63,386Nayer Khazeni · Stanford University · F32 · FY2008 · HS
Computational Models of Infectious Disease Threats
$63,240Donald S. Burke · University Of Pittsburgh At Pittsburgh · U54 · FY2012 · GM
Mechanisms of STING-Mediated Mucosal Vaccine Adjuvant Activity of Cyclic di-GMP
$63,221Lei Jin · Albany Medical College · R01 · FY2016 · AI
Cytomegalovirus and diseases of aging: a secondary analysis of NHANES III data
$63,140Ann B Hill · Oregon Health & Science University · R03 · FY2012 · AG
Cytomegalovirus and diseases of aging: a secondary analysis of NHANES III data
$63,140Ann B Hill · Oregon Health & Science University · R03 · FY2011 · AG
Role of ILC2s in lung maintenance and repair
$63,034Maya Kotas · University Of California, San Francisco · F32 · FY2018 · HL
Inducible HMGB1 antagonist for viral-induced acute lung injury.
$62,894Jorge C Blanco · Sigmovir Biosystems, Inc. · R41 · FY2024 · HL
Core D: Clinical Recruitment
$62,873Albert C Shaw · Yale University · U19 · FY2019 · AI
Epigenetic modifiers of regulatory T cell function following viral pneumonia
$62,868Benjamin David Singer · Northwestern University At Chicago · R01 · FY2021 · HL
New Mexico Occupational Health Surveillance Program
$62,850Srikanth Paladugu · New Mexico State Department Of Health · U60 · FY2023 · OH
Administrative Core
$62,838Mark M Davis · Stanford University · U19 · FY2016 · AI
Key determinants of dengue virus neutralization by naturally occurring human mAbs
$62,744Scott Alan Smith · Vanderbilt University Medical Center · K08 · FY2015 · AI
ENHANCEMENT OF NEW MEXICO DEPT OF HEALTHS INFLUENZA SURVEILLANCE PROGRAM
$62,657Joan Baumbach · New Mexico State Department Of Health · U50 · FY2007 · CI
Aging and Immunity to Infection
$62,527Laura Haynes · University Of Connecticut Sch Of Med/Dnt · P01 · FY2013 · AG
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
$62,300Jay R Radke · Idaho Veterans Research / Education Fdn · R03 · FY2023 · AI
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
$62,300Jay R Radke · Idaho Veterans Research / Education Fdn · R03 · FY2024 · AI
Folding RNA: Influenza
$62,043Douglas H. Turner · University Of Rochester · R03 · FY2011 · TW
Understanding fusion peptide mutations in influenza hemagglutinin
$61,964Peter M Kasson · University Of Virginia · R01 · FY2016 · GM